SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman
SIGA Technologies Inc. (SIGA)
US:NASDAQ Investor Relations:
investor.siga.com/investor-relations
Company Research
Source: GlobeNewswire
SAN FRANCISCO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical company SIGA Technologies is under intense scrutiny over its prior disclosures regarding the potential expansion of its lead product, TPOXX®, to treat Mpox. Hagens Berman encourages SIGA Technologies, Inc. (NASDAQ: SIGA) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys. Visit: www.hbsslaw.com/investor-fraud/siga Contact the Firm Now: SIGA@hbsslaw.com 844-916-0895 Investigation Into SIGA Technologies, Inc. (SIGA): The inquiry centers on the company’s statements about the likelihood of securing FDA approval to broaden the drug’s label. In October 2022, SIGA initiated clinical trials to assess TPOXX®’s safety and efficacy for Mpox treatment in the Democratic Republic of Congo. SIGA’s CEO, Diem Nguyen, has consistently emphasiz
Show less
Read more
Impact Snapshot
Event Time:
SIGA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SIGA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SIGA alerts
High impacting SIGA Technologies Inc. news events
Weekly update
A roundup of the hottest topics
SIGA
News
- Are Investors Undervaluing Siga Technologies (SIGA) Right Now? [Yahoo! Finance]Yahoo! Finance
- Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced [Yahoo! Finance]Yahoo! Finance
- Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox AnnouncedGlobeNewswire
- Siga Technologies (SIGA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]Yahoo! Finance
SIGA
Sec Filings
- 12/13/24 - Form 8-K
- 12/10/24 - Form 8-K
- 11/8/24 - Form SC
- SIGA's page on the SEC website